Views & Analysis Patient-centric trials – dream or reality? Many pharma companies claim to put patients at the heart of research, but how many live up to these expectations?
Views & Analysis Horses or zebras: inspiring behavioural change to make the r... Insight into human behaviour allows development of programmes that help doctors diagnose rare diseases.
Views & Analysis The Berlin Declaration – driving early action in type 2 diab... International initiative helps countries focus on best policies for overcoming diabetes.
Views & Analysis Patient power in Europe – more work to be done What the EMA and pharma can do to promote patient involvement in decision making.
Views & Analysis The tools of choice in person-centred care NHS England’s chief executive, Simon Stevens, recently stated that focus must be put on care in the community and in the home to tackle the huge deficits facing NHS trusts.
News Pharma must slash rare disease drug prices - patient organis... More rare disease drugs must also be approved, says EURORDIS.
News UK offers meningitis jab to young people after outbreak The UK government has responded to calls to broaden vaccinations for meningitis B, offering the jab to "thousands" of young people this summer.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
